Medicine Man Technologies, Inc.
SHWZ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $172 | $159 | $108 | $24 |
| % Growth | 8.2% | 47% | 351.7% | – |
| Cost of Goods Sold | $96 | $74 | $59 | $17 |
| Gross Profit | $76 | $85 | $49 | $7 |
| % Margin | 44.1% | 53.4% | 45.5% | 28.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $71 | $7 | $39 | $30 |
| SG&A Expenses | $71 | $59 | $39 | $30 |
| Sales & Mktg Exp. | $0 | $53 | $0 | $0 |
| Other Operating Expenses | $2 | $8 | $0 | $0 |
| Operating Expenses | $73 | $67 | $39 | $30 |
| Operating Income | $3 | $13 | $10 | -$23 |
| % Margin | 1.9% | 8.1% | 9.6% | -95.4% |
| Other Income/Exp. Net | -$18 | -$16 | $9 | $3 |
| Pre-Tax Income | -$15 | -$4 | $19 | -$20 |
| Tax Expense | $20 | $15 | $4 | -$1 |
| Net Income | -$35 | -$18 | $15 | -$19 |
| % Margin | -20% | -11.6% | 13.4% | -80.9% |
| EPS | -0.26 | -0.49 | 0.17 | -0.47 |
| % Growth | 46.9% | -388.2% | 136.2% | – |
| EPS Diluted | -0.26 | -0.49 | -0.06 | -0.47 |
| Weighted Avg Shares Out | 65 | 54 | 43 | 41 |
| Weighted Avg Shares Out Dil | 65 | 54 | 43 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $32 | $30 | $7 | $0 |
| Depreciation & Amortization | $21 | $12 | $9 | $0 |
| EBITDA | $38 | $38 | $35 | -$20 |
| % Margin | 22.1% | 23.9% | 31.8% | -82.5% |